WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that Paul L. Berns, President and Chief Executive Officer, and members of Allos’ senior management team will provide a company update and review 2008 results via webcast and conference call on Tuesday, March 3, 2009, at 4:15 p.m. ET.
